All In Biotech

Drug Trial Radar · NCT05014568

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Last checked: Nov 20, 2026Latest source record: Sep 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 407 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

407

Actual

Start

Sep 1, 2021

Primary completion

Mar 30, 2023

Study completion Apr 7, 2023

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Aug 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • tapinarof cream, 1%Drug

    applied topically once daily

  • Vehicle creamDrug

    applied topically once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects Who Have a Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) Score of Clear or Almost Clear (0 or 1) With a Minimum 2-grade Improvement From Baseline to Week 8. Analyses Were Done Using Multiple Imputation.Time frame: Baseline to Week 8

Locations

67 sites in 2 countries. Site status is shown where the registry gives one.

  • Dermavant Investigative Site

    Birmingham, Alabama

  • Dermavant Investigative Site

    Phoenix, Arizona

  • Dermavant Investigative Site

    Bryant, Arkansas

  • Dermavant Investigative Site

    Beverly Hills, California

  • Dermavant Investigative Site

    Fountain Valley, California

  • Dermavant Investigative Site

    Fremont, California

  • Dermavant Investigative Site

    Inglewood, California

  • Dermavant Investigative Site

    Los Angeles, California

  • Dermavant Investigative Site

    Los Angeles, California

  • Dermavant Investigative Site

    Mission Viejo, California

  • Dermavant Investigative Site

    Sacramento, California

  • Dermavant Investigative Site

    Washington D.C., District of Columbia

  • Dermavant Investigative Site

    Boca Raton, Florida

  • Dermavant Investigative Site

    Boca Raton, Florida

  • Dermavant Investigative Site

    Brandon, Florida

  • Dermavant Investigative Site

    Coral Gables, Florida

  • Dermavant Investigative Site

    Jacksonville, Florida

  • Dermavant Investigative Site

    Margate, Florida

  • Dermavant Investigative Site

    Miami, Florida

  • Dermavant Investigative Site

    Miami Lakes, Florida

  • Dermavant Investigative Site

    Orlando, Florida

  • Dermavant Investigative Site

    Pinellas Park, Florida

  • Dermavant Investigative Site

    Sweetwater, Florida

  • Dermavant Investigative Site

    Tampa, Florida

  • Dermavant Investigative Site

    Marietta, Georgia

  • Dermavant Investigative Site

    Sandy Springs, Georgia

  • Dermavant Investigative Site

    Savannah, Georgia

  • Dermavant Investigative Site

    Plainfield, Indiana

  • Dermavant Investigative Site

    Louisville, Kentucky

  • Dermavant Investigative Site

    Owensboro, Kentucky

  • Dermavant Investigative Site

    Covington, Louisiana

  • Dermavant Investigative Site

    Monroe, Louisiana

  • Dermavant Investigative Site

    Largo, Maryland

  • Dermavant Investigative Site

    Bay City, Michigan

  • Dermavant Investigative Site

    Clarkston, Michigan

  • Dermavant Investigative Site

    Warren, Michigan

  • Dermavant Investigative Site

    Ypsilanti, Michigan

  • Dermavant Investigative Site

    New Brighton, Minnesota

  • Dermavant Investigative Site

    Missoula, Montana

  • Dermavant Investigative Site

    Omaha, Nebraska

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.